FDA Approved: ESBRIET — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approves Esbriet (pirfenidone) from Genentech in an Original Application for the treatment of idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)

Snippet

ORIG AP for ESBRIET (PIRFENIDONE)